| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 11 | 17 | 27 | 25 | 30 | 33 | 19 |
| Expenses | 11 | 17 | 26 | 22 | 29 | 30 | 18 |
| EBITDA | 0 | 0 | 1 | 3 | 1 | 3 | 1 |
| Operating Profit % | 1 % | 2 % | 4 % | 12 % | 3 % | 9 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 3 | 1 | 3 | 1 |
| Tax | 0 | 0 | 0 | 1 | 0 | 1 | -0 |
| Net Profit | 0 | 0 | 1 | 2 | 0 | 2 | 2 |
| EPS in ₹ | 0.37 | 1.66 | 2.59 | 6.81 | 0.68 | 4.66 | 6.60 |
Sunrest Lifescience
Sunrest Lifescience
38.00
0.00
(0.00%)
Market Cap
32.61 Cr
PE Ratio
16.24
Volume
0.00
Day High - Low
- - -
52W High-Low
61.00 - 29.55
Key Fundamentals
Market Cap
32.61 Cr
EPS
4.66
PE Ratio
16.24
PB Ratio
1.04
Book Value
36.51
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
12.36
Debt to Equity
0.41
Actual
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,863.20 | #1 4,47,044.09 | 39.96 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 63.20 | |
6,921.50 | 1,83,744.08 | 72.74 | 9,712.00 | 18.67 | 2,191 | -1.02 | 76.54 | |
4,403.90 | 1,49,047.99 | 63.98 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.43 | |
1,436.70 | 1,16,053.85 | 27.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 70.81 | |
1,303.60 | 1,08,804.06 | 25.40 | 33,593.30 | -0.44 | 3,998 | -86.05 | 54.59 | |
2,258.20 | 1,03,209.50 | 18.91 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 43.90 | |
2,462.20 | 1,01,640.86 | 55.11 | 12,744.20 | 20.90 | 2,007 | 7.65 | 70.95 | |
991.70 | 99,788.22 | #1 18.80 | 23,511.00 | 18.55 | 4,615 | -0.32 | 66.36 | |
1,510.90 | 87,753.32 | 24.96 | 32,345.60 | 9.43 | 3,484 | 7.59 | 73.72 | |
1,315.50 | 71,018.13 | 77.65 | 6,812.90 | #1 21.03 | 884 | 21.18 | 79.66 |
Growth Rate
Revenue Growth
12.20 %
Net Income Growth
900.00 %
Cash Flow Change
109.66 %
ROE
677.36 %
ROCE
206.96 %
EBITDA Margin (Avg.)
194.16 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6 | 10 | 13 | 17 | 25 | 35 |
| Fixed Assets | 0 | 0 | 1 | 0 | 0 | 1 |
| Current Assets | 6 | 9 | 13 | 16 | 25 | 28 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 9 | 13 | 16 | 25 | 34 |
| Total Equity & Liabilities | 6 | 10 | 13 | 17 | 25 | 35 |
| Current Liabilities | 4 | 7 | 9 | 12 | 8 | 15 |
| Non Current Liabilities | 2 | 2 | 3 | 2 | 4 | 4 |
| Total Equity | 0 | 0 | 1 | 3 | 14 | 16 |
| Reserve & Surplus | 0 | 0 | 1 | 0 | 10 | 12 |
| Share Capital | 0 | 0 | 0 | 3 | 4 | 4 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 0 | -0 | 0 |
| Investing Activities | 0 | -0 | -0 | 0 | 0 | -1 |
| Operating Activities | -1 | 0 | -0 | 1 | -15 | 1 |
| Financing Activities | 1 | 0 | 1 | -1 | 15 | -0 |
Share Holding
| % Holding | Nov 2023 | Mar 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 53.50 % | 53.50 % | 53.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 25.24 % | 24.46 % | 24.87 % | 24.83 % | 24.94 % | 24.27 % | 36.02 % | 34.90 % | 36.35 % |
| Others | 4.85 % | 5.63 % | 5.22 % | 5.26 % | 5.15 % | 5.82 % | 10.48 % | 11.60 % | 10.14 % |
| No of Share Holders | 742 | 580 | 505 | 487 | 459 | 455 | 498 | 491 | 492 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 61.40 | 60.45 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 56.15 | 57.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 56.50 | 52.05 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 46.50 | 47.20 |
| 23 Mar 2026 |  Rights | 1:1 | 23 Mar 2026 | 46.00 | 44.60 |
Technical Indicators
RSI(14)
Neutral 51.99
ATR(14)
Less Volatile 1.73
STOCH(9,6)
Neutral 47.65
STOCH RSI(14)
Overbought 83.73
MACD(12,26)
Bullish 0.27
ADX(14)
Weak Trend 13.16
UO(9)
Bearish 41.58
ROC(12)
Uptrend And Accelerating 2.98
WillR(14)
Neutral -54.55
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
